| Symbol | Company | Weighting |
|---|---|---|
| ABVX | ABIVAX SA | 19.76% |
| INSM | INSMED INC | 3.24% |
| KRRO | KORRO BIO | 2.55% |
| TVTX | TRAVERE THERAPEUTICS INC | 2.39% |
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORPORATION | 2.32% |
| CYTK | CYTOKINETICS INC | 2.26% |
| EYPT | EYEPOINT PHARMACEUTICALS | 2.14% |
| DYN | DYNE THERAPEUTICS, INC. | 2.11% |
| IMVT | IMMUNOVANT INC | 1.94% |
| TARS | TARSUS PHARMACEUTICALS | 1.86% |
| PSNL | PERSONALIS | 1.84% |
| RVMD | REVOLUTION MEDICINES INC | 1.78% |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1.72% |
| ARGX | ARGENX SE ADR | 1.67% |
| AKRO | AKERO THERAPEUTICS INC | 1.64% |
| CRNX | CRINETICS PHARMACEUTICALS INC | 1.62% |
| HALO | HALOZYME THERAPEUTICS INC | 1.56% |
| PCVX | VAXCYTE INC | 1.50% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.48% |
| THC | TENET HEALTHCARE CORP | 1.47% |
| HCA | HCA HOLDINGS INC | 1.44% |
| ICLR | ICON PLC | 1.43% |
| AZN | ASTRAZENECA PLC-ADR | 1.41% |
| EWTX | EDGEWISE THERAPEUTICS | 1.40% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.38% |
| RGEN | REPLIGEN CORP | 1.37% |
| MCK | MCKESSON CORP | 1.35% |
| ABBV | ABBVIE INC | 1.35% |
| DHR | DANAHER CORP | 1.32% |
| DNLI | DENALI THERAPEUTICS INC. | 1.28% |
| UNH | UNITEDHEALTH GROUP INC | 1.27% |
| HUM | HUMANA INC | 1.26% |
| MDT | MEDTRONIC PLC | 1.24% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.22% |
| GMED | GLOBUS MEDICAL INC CLASS A | 1.18% |
| BDX | BECTON DICKINSON & CO | 1.17% |
| RMD | RESMED INC | 1.17% |
| SNY | SANOFI- AVENTIS- ADR | 1.12% |
| ISRG | INTUITIVE SURGICAL INC | 1.10% |
| BSX | BOSTON SCIENTIFIC | 1.09% |
| SYK | STRYKER CORP | 1.09% |
| ABT | ABBOTT LABORATORIES | 1.09% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.06% |
| GKOS | GLAUKOS CORPORATION | 1.06% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.05% |
| CDXS | CODEXIS INC | 1.04% |
| REGN | REGENERON PHARMACEUTICALS | 1.03% |
| VCEL | VERICEL CORP | 1.03% |
| ALC | ALCON INC | 0.99% |
| ELV | ELEVANCE HEALTH INC | 0.97% |
| LENZ | LENZ THERAPEUTICS | 0.95% |
| ADMA | ADMA BIOLOGICS, INC. | 0.93% |
| SMMT | SUMMIT THERAPEUTICS INC. | 0.90% |
| ZTS | ZOETIS INC | 0.85% |
| DXCM | DEXCOM INC | 0.82% |
| SPRY | ARS PHARMACEUTICALS | 0.79% |
| TNDM | TANDEM DIABETES CARE INC | 0.76% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 0.62% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.61% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.